Influence of rosuvastatin in endothelial function and oxidative stress, in patients with acute coronary syndrome;Impacto del uso de rosuvastatina en los primeros días de un síndrome coronario agudo en la función endotelial y el poder oxidativo

Archivos de Cardiologia de Mexico

Volumn 78, Issue 4, 2008, Pages 379-383

  Nagay Hernández, Sandra ^d   Molina, Juan José Flores ^e   Lomelí, Hermes Ilarraza ^a   Sánchez, Carlos Martínez ^b   Mondragón, Leonardo Del Valle ^e   López, Fermín Alejandro Tenorio ^e   Hernández, Gustavo Pastelín ^c  

^a Servicio de Rehabilitación Cardíaca Y Medicina Física

^b Departamento de Urgencias Y Unidad Coronaria

^c INSTITUTO NACIONAL DE CARDIOLOGÍA IGNACIO CHÁVEZ   (Mexico)

^d Departamento Cardiovascular

^e NONE

Author keywords

Acute coronary syndrome; Endothelial function; Myocardial infarction; Nitric oxide; Oxidative stress; Statins

Indexed keywords

NITRIC OXIDE; PLACEBO; ROSUVASTATIN;

ACUTE CORONARY SYNDROME; ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFECT; ENDOTHELIAL DYSFUNCTION; FEMALE; HUMAN; MALE; OXIDATIVE STRESS; RANDOMIZED CONTROLLED TRIAL;

ACUTE CORONARY SYNDROME; AGED; ENDOTHELIUM, VASCULAR; FEMALE; FLUOROBENZENES; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; MALE; MIDDLE AGED; NITRIC OXIDE; OXIDATIVE STRESS; PYRIMIDINES; SULFONAMIDES;

EID: 58149252195     PISSN: 14059940     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (9)

1. a Cátedra de Med 2005; 151: 17-19.
2. PEDERSEN TR, KJEKSHUS J, BERG K: Randomized trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S). Lancet 1994; 344: 1383-1389.
3. UNDAS A, CELINSKA-LÖWENHOFF M, DOMAGALA TB, IWANIEC T, DROPINSKI J, LÖWENHOFF T, ET AL: Early antithrombotic and anti-inflammatory effects of simvastatin versus fenofibrate in patients with hypercholesterolemia. Thromb Haemost. 2005; 94 (1):193-199.
4. LI XP, ZHAOS P, LI J, LI JD, XIE XM, PERG J: The effect of early fluvastatin therapy on inflammatory factors in acute coronary syndrome. Zhonghua Nei Ke Za Zhi 2005; 44(3): 184-187.
5. STENESTRAND U, WALLENTIN L: Early statin treatment following acute myocardial infarction and 1-year survival. JAMA 2001; 285: 430-436.
6. Laufs U, La Fata V, Plutzky J, Liao JK: Up-regulation of endothelial nitric oxide synthase by HMG CoA reductas inhibitors. Circulation 1998; 97: 1129-35.
7. TENORIO LFA, DEL VALLE ML, PASTELÍN HG: Validación de un método analítico espectrofotométrico para la cuantificación de metabolitos estables de óxido nítrico en fluides biológicos. Rev Mex Cienc Farm 2005; 36(1): 31-41.
8. BAHR P, BASULTO Y: El potencial redactor férrico (FRP). Un ensayo para evaluar la capacidad antioxidante en suero. Corr Cient Med Holguín 2004; 8(4): 1-7.
9. RIDKER PM, DANIELSON E, FONSECA F, GENET J, GOTTO AM, ET AL: Rosuvastatin to prevent vascular events in men and women with elevated C reactive protein. New England Journal of Medicine 2008; 259: 2195-2207.